Predicting response to chemoradiotherapy in rectal cancer via visual morphologic assessment and staging on baseline MRI : a multicenter and multireader study

© 2023. The Author(s)..

PURPOSE: Pre-treatment knowledge of the anticipated response of rectal tumors to neoadjuvant chemoradiotherapy (CRT) could help to further optimize the treatment. Van Griethuysen et al. proposed a visual 5-point confidence score to predict the likelihood of response on baseline MRI. Aim was to evaluate this score in a multicenter and multireader study setting and compare it to two simplified (4-point and 2-point) adaptations in terms of diagnostic performance, interobserver agreement (IOA), and reader preference.

METHODS: Twenty-two radiologists from 14 countries (5 MRI-experts,17 general/abdominal radiologists) retrospectively reviewed 90 baseline MRIs to estimate if patients would likely achieve a (near-)complete response (nCR); first using the 5-point score by van Griethuysen (1=highly unlikely to 5=highly likely to achieve nCR), second using a 4-point adaptation (with 1-point each for high-risk T-stage, obvious mesorectal fascia invasion, nodal involvement, and extramural vascular invasion), and third using a 2-point score (unlikely/likely to achieve nCR). Diagnostic performance was calculated using ROC curves and IOA using Krippendorf's alpha (α).

RESULTS: Areas under the ROC curve to predict the likelihood of a nCR were similar for the three methods (0.71-0.74). IOA was higher for the 5- and 4-point scores (α=0.55 and 0.57 versus 0.46 for the 2-point score) with best results for the MRI-experts (α=0.64-0.65). Most readers (55%) favored the 4-point score.

CONCLUSIONS: Visual morphologic assessment and staging methods can predict neoadjuvant treatment response with moderate-good performance. Compared to a previously published confidence-based scoring system, study readers preferred a simplified 4-point risk score based on high-risk T-stage, MRF involvement, nodal involvement, and EMVI.

Medienart:

E-Artikel

Erscheinungsjahr:

2023

Erschienen:

2023

Enthalten in:

Zur Gesamtaufnahme - volume:48

Enthalten in:

Abdominal radiology (New York) - 48(2023), 10 vom: 05. Okt., Seite 3039-3049

Sprache:

Englisch

Beteiligte Personen:

El Khababi, Najim [VerfasserIn]
Beets-Tan, Regina G H [VerfasserIn]
Tissier, Renaud [VerfasserIn]
Lahaye, Max J [VerfasserIn]
Maas, Monique [VerfasserIn]
Curvo-Semedo, Luís [VerfasserIn]
Dresen, Raphaëla C [VerfasserIn]
Nougaret, Stephanie [VerfasserIn]
Beets, Geerard L [VerfasserIn]
Lambregts, Doenja M J [VerfasserIn]
rectal MRI study group [VerfasserIn]
Bakers, Frans C H [Sonstige Person]
Barros, Perla [Sonstige Person]
Bauer, Ferdinand [Sonstige Person]
de Bie, Shira H [Sonstige Person]
Ballantyne, Stuart [Sonstige Person]
Dutra, Joanna Brayner [Sonstige Person]
Buskov, Laura [Sonstige Person]
Bogveradze, Nino [Sonstige Person]
Bosma, Gerlof P T [Sonstige Person]
Cappendijk, Vincent C [Sonstige Person]
Castagnoli, Francesca [Sonstige Person]
Charalampos, Sotiriadis [Sonstige Person]
Delli Pizzi, Andrea [Sonstige Person]
Digby, Michael [Sonstige Person]
Geenen, Remy W F [Sonstige Person]
van Griethuysen, Joost J M [Sonstige Person]
Lafrance, Julie [Sonstige Person]
Mahajan, Vandana [Sonstige Person]
Malekzadeh, Sonaz [Sonstige Person]
Neijenhuis, Peter A [Sonstige Person]
Peterson, Gerald M [Sonstige Person]
Pieters, Indra [Sonstige Person]
Schurink, Niels W [Sonstige Person]
Smit, Ruth [Sonstige Person]
Veeken, Cornelis J [Sonstige Person]
Vliegen, Roy F A [Sonstige Person]
Wray, Andrew [Sonstige Person]
Zeina, Abdel-Rauf [Sonstige Person]

Links:

Volltext

Themen:

Chemoradiotherapy
Journal Article
Magnetic resonance imaging
Multicenter Study
Rectal cancer
Research Support, Non-U.S. Gov't
Response

Anmerkungen:

Date Completed 07.09.2023

Date Revised 03.10.2023

published: Print-Electronic

Citation Status MEDLINE

doi:

10.1007/s00261-023-03961-7

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM358599571